Related Experiment Video
Updated: Aug 29, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Obstetric Emergency Update: Severe Acute Respiratory Syndrome COVID-19 and Hypertension
1Center for Fetal Diagnosis and Treatment, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Insights
Pregnant and postpartum women require special attention for Coronavirus disease 2019 (COVID-19) and hypertension. Recognizing abnormal vital signs and lab values is crucial for prompt treatment to reduce morbidity and mortality.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Cardiology
Background:
- Pregnancy and the postpartum period present unique physiological states.
- Maternal morbidity and mortality are significant concerns in obstetric care.
- Emerging infectious diseases and pre-existing conditions pose risks to maternal health.
Purpose of the Study:
- To highlight the critical importance of Coronavirus disease 2019 (COVID-19) in pregnant and postpartum women.
- To emphasize the significant impact of hypertension on maternal outcomes.
- To advocate for vigilant monitoring and timely intervention in high-risk obstetric patients.
Main Methods:
- Review of current literature and clinical guidelines regarding COVID-19 in pregnancy.
- Analysis of the effects of hypertension on maternal and fetal health.
- Discussion of specialized vital sign and laboratory value parameters for pregnant and postpartum populations.
Main Results:
- COVID-19 infection can lead to severe illness, increased morbidity, and mortality in pregnant and postpartum individuals.
- Hypertension, both pre-existing and gestational, is a major contributor to adverse maternal outcomes.
- Standard vital sign and laboratory reference ranges may not be appropriate for pregnant and postpartum women, necessitating tailored monitoring.
Conclusions:
- Early recognition of abnormal clinical parameters is essential for effective management of COVID-19 and hypertension in pregnant and postpartum women.
- Adherence to stringent, population-specific guidelines for vital signs and laboratory values is critical for timely and appropriate treatment.
- Proactive monitoring and rapid intervention strategies are key to improving maternal and infant outcomes in the context of these significant health challenges.
Abstract:
The purpose of this article is to bring attention to 2 topics of significant importance to the care of pregnant women and women who have recently given birth. Coronavirus disease 2019 and hypertension can have a significant impact on morbidity and mortality for these pregnant and postpartum women. Although women in their childbearing years are for the most part young and healthy, it is critically important to recognize that these patients have more stringent guidelines for vital signs and laboratory values, which should be noticed as abnormal for rapid treatment as necessary.
More Related Videos
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
Related Concept Videos
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Errors occurring during blood pressure monitoring
Several factors...